CN103232544A - Recombination porcine interferon gamma-Fc fusion protein as well as coding gene and expression method thereof - Google Patents

Recombination porcine interferon gamma-Fc fusion protein as well as coding gene and expression method thereof Download PDF

Info

Publication number
CN103232544A
CN103232544A CN2013101817655A CN201310181765A CN103232544A CN 103232544 A CN103232544 A CN 103232544A CN 2013101817655 A CN2013101817655 A CN 2013101817655A CN 201310181765 A CN201310181765 A CN 201310181765A CN 103232544 A CN103232544 A CN 103232544A
Authority
CN
China
Prior art keywords
fusion rotein
pig interferon
interferon
reorganization
pig
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2013101817655A
Other languages
Chinese (zh)
Other versions
CN103232544B (en
Inventor
马永
王安良
章成昌
徐春林
陈晨
王耀方
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Jingsen Biomedical New Materials Technology Co., Ltd.
Original Assignee
CHANGZHOU GENSUN INSTITUTE OF BIOMEDICINE Co Ltd
ZONHON BIOPHARMA INSTITUTE Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHANGZHOU GENSUN INSTITUTE OF BIOMEDICINE Co Ltd, ZONHON BIOPHARMA INSTITUTE Inc filed Critical CHANGZHOU GENSUN INSTITUTE OF BIOMEDICINE Co Ltd
Priority to CN201310181765.5A priority Critical patent/CN103232544B/en
Publication of CN103232544A publication Critical patent/CN103232544A/en
Application granted granted Critical
Publication of CN103232544B publication Critical patent/CN103232544B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

The invention provides a recombination porcine IFN (interferon) gamma-Fc fusion protein as well as a coding gene and expression, purification and inclusion body renaturation methods of the recombination porcine IFN alpha1-Fc fusion protein, which belong to the field of biology gene engineering. IFN gamma is synthesized of T cells and NK cells and has broad-spectrum antivirus and immune regulation functions and an important influence on the occurrence and development of diseases. Natural porcine IFN gamma expressed in an organism is insufficient for a large quantity of clinical studies and application, and the defect of fast clearing speed of the IFN gamma 1 in blood plasma exists. The recombination porcine IFN gamma-Fc fusion protein, which is provided by the invention, is suitable for an escherichia coli prokaryotic expression system, wherein a porcine IFN gamma part is an entire sequence of a porcine IFN gamma extracellular region, an Fc fragment part comprises a hinge region, a CH2 region and a CH3 region of an antibody, and the porcine IFN gamma part and the Fc fragment part are directly fused. The fusion protein provided by the invention has biological activity higher than that of the original protein IFN gamma, the half-life period of the fusion protein is greatly prolonged, and an opportunity is provided for industrial development of the fusion protein.

Description

A kind of reorganization pig interferon γ-Fc fusion rotein and encoding gene and expression method
Technical field
The invention belongs to biotechnology gene field, relate to a kind of reorganization pig interferon γ-Fc fusion rotein and encoding gene thereof, with and expression, purifying and renaturing inclusion bodies method.
Background technology
(Interferon is one group of active protein (mainly being glycoprotein) with multiple function IFN) to Interferon, rabbit, is a kind of cytokine that is produced by monocyte and lymphocyte.They allogenic cell have wide spectrum antiviral, influence cell growth, and differentiation, regulate multiple biological activity such as immunologic function.According to the source of IFN be the character of animal species, cell type, inducer with to induce condition different, can be divided into three kinds of α, β, γ.Wherein, IFN-(interferon, IFN-γ) have the title of type II interferon, synthetic by T cell and NK cell, its biological effect comprises antiviral activity, anti-tumour cell proliferative, induces MHCI level antigen presentation, induces MHC II level antigen presentation, activates M φ, make its killing tumor cell and kill the bag entozoa.This shows that interferon-gamma not only has the broad-spectrum antiviral function, also have immunoregulatory effect, to the control important influence of the generation of disease development.
China is the big country of raising pigs, and multiple pig virus transmissible diseases such as pig circular ring virus 2 viral disease, porcine reproductive and respiratory syndrome, porcine pseudorabies have been brought enormous economic loss to pig industry.Though China extensively inoculates various swine disease vaccines at present, still can not effectively control disease popularity.Genetically engineered animal-use drug interferon-can effectively strengthen the immunologic function of porkling, improves body to the defense reaction of virus, and have drug residue free, characteristics such as have no side effect, be subjected to clinical animal doctor and raiser's favor deeply.But the biological effect of interferon-has the species specificity of height, and that natural pig interferon γ expresses in body is very little, is difficult to directly that a large amount of the extraction supplies clinical study and application in the body.Therefore the present invention provides a kind of with low cost and can great expression reorganization pig interferon γ expression system and expression method by genetic engineering means.
On the other hand, as small molecular weight protein, pig interferon γ is also the same with other interferon-gammas, has plasma clearance speed defective faster, just can reach result for the treatment of thereby cause needing to repeat repeatedly medication in clinical treatment.Therefore, the frequent bottleneck that uses pig interferon γ treatment pig virus disease that also will become of transformation period weak point and medication.The IgG immunoglobulin (Ig) is the main antibody in the humans and animals body, and its transformation period in vivo is about 20 days.Its stability be since the Fc fragment of IgG can with newborn Fc acceptor (FcRn) combination, avoid IgG to enter in the lysosome and be degraded.In view of this, the present invention attempts considering that the Fc fragment that increases IgG at pig interferon γ constitutes fusion rotein, to improve the transformation period in the pig interferon γ body, reaches long-acting purpose.Thus, the purpose of this invention is to provide and a kind ofly can keep the original activity of pig interferon γ, again can extension body in the pig interferon γ of transformation period and the fusion rotein of Fc fragment.
Yet, the recombinant protein by escherichia coli expression mostly be do not dissolve, aggregation, i.e. inclusion body in the cell of non-activity.The renaturation of inclusion body is a very complicated process, if the renaturation condition is not suitable for occurring the mispairing of intramolecular disulfide bond, intermolecular covalent attachment or hydrophobic in conjunction with forming polymer, reduce the ratio motility rate of recombinant protein on the one hand, cause quality product defective, produce precipitation simultaneously again and separate out, influence yield.Therefore, another technical problem to be solved by this invention is to adopt suitable method that the albumen inclusion body of escherichia coli expression is carried out renaturation.
Summary of the invention
The objective of the invention is to overcome the deficiencies in the prior art part, by codon optimized mode, provide a kind of reorganization pig interferon γ-Fc fusion rotein that can in intestinal bacteria, efficiently express with and gene and expression, purifying, refolding method.
The invention provides reorganization pig interferon γ-Fc fusion rotein, described fusion rotein comprises pig interferon gamma portion and Fc fragment part, wherein, the pig interferon gamma portion is the full sequence of pig interferon γ extracellular region, the Fc fragment partly comprises hinge area, CH2 district and CH3 district, is directly to merge between pig interferon γ and the Fc fragment part.
Fc fragment wherein is selected from human or animal's immunoglobulin Fc, is Fc total length or partial sequence, and Fc is selected from IgG, IgM, IgD, IgA, and every kind of immunoglobulin class comprises each hypotype, as IgG1, IgG2, IgG3, IgG4.The preferred especially IgG1 from pig of Fc fragment part in the fusion rotein of the present invention.
Preferably, reorganization pig interferon γ of the present invention-Fc fusion rotein has the aminoacid sequence shown in the SEQ ID NO:2, and wherein 2-144 amino acids residue is the extracellular region sequence of pig interferon γ, and 145-374 amino acids residue is pig IgG 1 sequence.
The invention provides the gene of coding reorganization pig interferon γ described above-Fc fusion rotein, its base sequence is shown in SEQ ID NO:1.This sequence is to aim at escherichia expression system to carry out the codon optimized sequence that obtains, and can significantly improve the expression of heterologous gene in the host bacterium by contrast.
The present invention also provides the plasmid of the gene that has comprised coding reorganization pig interferon γ described above-Fc fusion rotein, and described plasmid is preferably prokaryotic expression plasmid, most preferably is the pET21b carrier.
The present invention also provides the coli strain that includes plasmid described above, and preferably, described bacterial strain is selected from e. coli bl21 (DE3) bacterial strain.
The present invention also provides reorganization pig interferon γ-Fc fusion rotein in the escherichia coli expression method, comprises the steps:
Steps of the method are:
Picking one or more contain the intestinal bacteria bacterium colony of reorganization pig interferon γ described above-Fc fusion rotein, insert the LB nutrient solution, in 37 ℃ of overnight incubation;
2. get an amount of overnight culture, insert in the LB nutrient solution of 100 times of amounts of described overnight culture, be cultured to mid-log phase OD in 37 ℃ of concussions 600=1.0;
3. adding concentration in culture is the IPTG of 1mmol/L, in 37 ℃, behind the abduction delivering 4h, in 4 ℃ with rotating speed 5000rpm, centrifugal treating 15min collects the coli somatic that contains reorganization pig interferon γ-Fc fusion rotein.
All contain penbritin 50-100 μ g/ml in the described LB nutrient solution.
Expression method described above of the present invention is that the effective means the most that is used for express recombinant pig interferon γ-Fc fusion rotein that obtains is groped and verified in experiment through contriver's repeated multiple times, the expression amount height of this method, and express obtain renaturing inclusion bodies after activity higher.
The present invention also provides the inclusion body purification method of reorganization pig interferon γ-Fc fusion rotein, comprises the steps:
1. above-mentioned the containing that collection is obtained induced reorganization pig interferon γ-Fc fusion rotein intestinal bacteria precipitation, and be resuspended with the PBS of precooling, and handle in 4 ℃ of high speed centrifugations; Repeat once.
2. inhale and remove supernatant, claim bacterial sediment weight, every gram (weight in wet base) adds lysis buffer Buffer A3-10mL, stirs damping fluid, and thalline is hanged.
3. every gram (weight in wet base) thalline adding 3-10 μ L concentration is the PMSF of 100mmol/L, and 3-100 μ L concentration is the N,O-Diacetylmuramidase of 100mg/mL, in stirring on ice.
4. broken thalline, sample places on ice, and is ultrasonic, and handles in 4 ℃ of high speed centrifugations.
5. precipitation is washed with lavation buffer solution Buffer B, and handles in 4 ℃ of high speed centrifugations, and the precipitation inclusion body repeats once.
6. the inclusion body precipitation stirs 30-60min with sex change buffer B uffer C dissolving under the room temperature.
7. the room temperature high speed centrifugation is handled behind the abundant mixing, abandons precipitation, gets supernatant, the pig interferon γ that namely obtains recombinating-Fc fusion rotein denaturing soln.
This purification process preferred steps is as follows:
1. above-mentioned the containing that collection is obtained induced reorganization pig interferon γ-Fc fusion rotein intestinal bacteria precipitation, and be resuspended with the PBS of precooling, in 4 ℃, with the centrifugal 15min of the rotating speed of 12000rpm; Repeat once.
2. inhale and remove supernatant, claim bacterial sediment weight, every gram (weight in wet base) adds lysis buffer Buffer A5mL, stirs with the slicking glass rod, and thalline is hanged.
3. to add 5 μ L concentration be the PMSF of 100mmol/L to every gram (weight in wet base) thalline, and 5 μ L concentration are the N,O-Diacetylmuramidase of 100mg/mL, stir 20min on ice.
4. with the broken thalline of sonde-type ultrasonoscope, sample places on ice, and ultrasonic 120 times, each 5s is 5s at interval, circulates three times, is circulated between the cooling sample at every turn and waits for 2min, waits for the sample cooling.In 4 ℃, with the centrifugal 15min of the rotating speed of 12000rpm, abandon supernatant.
5. precipitation is with lavation buffer solution Buffer B washing, and in 4 ℃, with the centrifugal 15min of the rotating speed of 12000rpm, the precipitation inclusion body repeats once.
6. the inclusion body precipitation stirs 30min with sex change buffer B uffer C dissolving under the room temperature.
Fully behind the mixing under the room temperature with the centrifugal 15min of the rotating speed of 12000rpm, abandon precipitation, get supernatant, the pig interferon γ that namely obtains recombinating-Fc fusion rotein denaturing soln.
The present invention also provides the renaturing inclusion bodies method of the reorganization pig interferon γ-Fc fusion rotein after optimizing, and comprises the steps:
Get an amount of reorganization pig interferon γ-Fc fusion rotein denaturing soln with sex change buffer B uffer C dissolving, with renaturation buffer Buffer D protein concentration is diluted to 0.2mg/mL, 4 ℃ of renaturation are during to 24h, recombinant protein solution after the renaturation with 0.45 μ m membrane filtration, is namely obtained the reorganization pig interferon γ-Fc fusion rotein solution of lower concentration.And further ultrafiltration desalination, concentrated, low-temperature vacuum drying namely obtains reorganization pig interferon γ-Fc fusion rotein powder.Composition and the content thereof of each damping fluid are as shown in the table:
Figure BDA00003196552900041
The present invention also provides pig interferon γ or the purposes of reorganization pig interferon γ – Fc fusion rotein in the medicine of preparation treatment and prevention porcine reproductive and respiratory syndrome, porcine influenza and pig blue-ear disease disease.In porkling disease treatment process, pig interferon γ or reorganization pig interferon γ – Fc fusion rotein can nonspecific performance antiviral effect widely, improve immune response and strengthen defence capability to virus.Simultaneously, pig interferon γ or reorganization pig interferon γ – Fc fusion rotein also can be united use with other vaccines, alleviate the untoward reaction of vaccine, strengthen whole antiviral, bacterium, parasitic effectiveness.Pig interferon γ or reorganization pig interferon γ – Fc fusion rotein also can be united use with multiple cause of disease vaccine, can significantly improve immune level, minimizing stress, reduce the side effect of vaccine, thereby reach stronger therapeutic action.
Reorganization pig interferon γ-Fc fusion rotein recombination sequence through optimizing of the present invention, be more suitable for the expression of escherichia expression system, expressed reorganization pig interferon γ-Fc fusion rotein is far above the expression amount of pig interferon γ-Fc fusion rotein natural gene sequence at escherichia expression system, and, γ compares with pig interferon, reorganization pig interferon γ of the present invention-Fc fusion rotein is guaranteeing to have prolonged its transformation period in vivo largely on the bioactive basis of pig interferon γ, has realized long-acting and avoids the purpose of medication repeatedly.Simultaneously, provided by the present invention is a boar source type fusion rotein, be more suitable for using the preparation at Swine virus disease veterinary drug, and the procaryotic cell expression of this fusion rotein provided by the present invention, purifying and refolding method have also been controlled its preparation cost greatly, realize industrialization for it possibility is provided.
Description of drawings
Fig. 1 represents to recombinate the pig interferon γ-codon optimized front and back of Fc fusion rotein nucleotide sequence relatively
Wherein, odd-numbered line (i.e. " original series " corresponding row) is pig interferon γ-Fc fusion rotein natural gene nucleotide sequence, i.e. codon optimized preceding sequence; Even number line (i.e. " majorizing sequence " corresponding row) is the gene nucleotide series of reorganization pig interferon γ of the present invention-Fc fusion rotein, the sequence after namely codon optimized.
Fig. 2-a, Fig. 2-b are the reorganization pig interferon γ-codon optimized front and back of Fc fusion rotein CAI index in the escherichia coli expression host.
Wherein, Fig. 2-a represent to recombinate pig interferon γ-Fc fusion rotein codon optimized before in the escherichia coli expression host CAI index be 0.64; Fig. 2-b codon optimized the back of pig interferon γ-Fc fusion rotein CAI index in the escherichia coli expression host of representing to recombinate is 0.84.
Fig. 3-a, Fig. 3-b are reorganization pig interferon γ-Fc fusion rotein codon optimum codon frequency distributed areas figure in the escherichia coli expression host.
Wherein, Fig. 3-a represent to recombinate pig interferon γ-Fc fusion rotein codon optimized before in the escherichia coli expression host optimum codon frequency distributed areas figure, as can be seen from the figure: it is 8% that per-cent appears in the reorganization pig interferon γ-poor efficiency codon (<30%) of the codon optimized presequence of Fc fusion rotein; Fig. 3-b codon optimized the back of pig interferon γ-Fc fusion rotein optimum codon frequency distributed areas figure in the escherichia coli expression host that represents to recombinate, it is 0 that per-cent appears in the reorganization pig interferon γ-poor efficiency codon (<30%) of the codon optimized presequence of Fc fusion rotein.
Fig. 4-a, Fig. 4-b in reorganization pig interferon γ-Fc fusion rotein codon in the escherichia coli expression host average GC base contents distributed areas figure.
Wherein, Fig. 4-a represent to recombinate pig interferon γ-Fc fusion rotein codon optimized before in the escherichia coli expression host average GC base contents be: 52.12%; Fig. 4-b codon optimized the back of pig interferon γ-Fc fusion rotein average GC base contents in the escherichia coli expression host of representing to recombinate is: 50.94%.
Fig. 5-a, Fig. 5-b are the secondary structure prediction figure of reorganization pig interferon γ-codon optimized front and back mRNA of Fc fusion rotein.
The secondary structure prediction figure of Fig. 5-a reorganization pig interferon γ-codon optimized premessenger RNA of Fc fusion rotein, Fig. 5-b is the secondary structure prediction figure of the reorganization pig interferon γ-codon optimized back of Fc fusion rotein mRNA.
Fig. 6 is reorganization pig interferon γ-Fc fusion protein expression plasmid building process figure.
Fig. 7 is reorganization pig interferon γ-Fc fusion rotein optimized gene agarose gel electrophoresis figure.
Wherein, swimming lane 1 is 500bp DNA Ladder; Swimming lane 2 is the pET21b carrier behind NdeI and the XhoI double digestion; Swimming lane 3 contains the reorganization pig interferon γ-Fc antigen-4 fusion protein gene PCR product of NdeI and XhoI restriction enzyme site for two ends.
Fig. 8 is SDS-PAGE gel electrophoresis figure and the corresponding western blot figure of reorganization pig interferon γ-Fc fusion rotein.
Fig. 8-a is reorganization pig interferon γ-Fc fusion rotein SDS-PAGE gel electrophoresis figure.
Wherein, swimming lane 1 is sample Marker on the albumen that dyes in advance of (10-230kDa) wide region; Swimming lane 2 is not for adding reorganization pig interferon γ-Fc fusion rotein intestinal bacteria lysate that IPTG induces; Swimming lane 3 is for adding reorganization pig interferon γ-Fc fusion rotein intestinal bacteria lysate that IPTG induces.
Fig. 8-b is reorganization pig interferon γ-Fc fusion protein immunization trace figure.
Wherein, swimming lane 1(10-230KDa) sample Marker on the albumen that dyes in advance of wide region, swimming lane 2 is not for adding reorganization pig interferon γ-Fc fusion rotein intestinal bacteria lysate that IPTG induces: swimming lane 3 is for adding reorganization pig interferon γ-Fc fusion rotein intestinal bacteria lysate that IPTG induces.
Fig. 9 pig interferon γ-Fc fusion rotein of recombinating efficiently expresses inductive condition and optimizes the SDS-PAGE gel electrophoresis figure.
Wherein, swimming lane 1 is sample Marker on the albumen that dyes in advance of (10-230kDa) wide region; Swimming lane 2 is induced 1h reorganization pig interferon γ-Fc fusion rotein intestinal bacteria lysate for 0.5mmol/L IPTG; Swimming lane 3 is induced 2h reorganization pig interferon γ-Fc fusion rotein intestinal bacteria lysate for 0.5mmol/L IPTG; Swimming lane 4 is induced 3h reorganization pig interferon γ-Fc fusion rotein intestinal bacteria lysate for 0.5mmol/L IPTG; Swimming lane 5 is induced 4h reorganization pig interferon γ-Fc fusion rotein intestinal bacteria lysate for 0.5mmol/L IPTG; Swimming lane 6 is induced 1h reorganization pig interferon γ-Fc fusion rotein intestinal bacteria lysate for 1mmol/L IPTG; Swimming lane 7 is induced 2h reorganization pig interferon γ-Fc fusion rotein intestinal bacteria lysate for 1mmol/LIPTG; Swimming lane 8 is induced 3h reorganization pig interferon γ-Fc fusion rotein intestinal bacteria lysate for 1mmol/L IPTG; Swimming lane 9 is induced 4h reorganization pig interferon γ-Fc fusion rotein intestinal bacteria lysate for 1mmol/L IPTG; Swimming lane 10 is induced 1h reorganization pig interferon γ-Fc fusion rotein intestinal bacteria lysate for 1.5mmol/L IPTG; Swimming lane 11 is induced 2h reorganization pig interferon γ-Fc fusion rotein intestinal bacteria lysate for 1.5mmol/L IPTG; Swimming lane 12 is induced 3h reorganization pig interferon γ-Fc fusion rotein intestinal bacteria lysate for 1.5mmol/L IPTG; Swimming lane 13 is induced 4h reorganization pig interferon γ-Fc fusion rotein intestinal bacteria lysate for 1.5mmol/L IPTG.
Figure 10 is the reorganization pig interferon γ-Fc fusion rotein inclusion body SDS-PAGE electrophorogram after the renaturation.
Wherein, swimming lane 1 is sample Marker on the albumen that dyes in advance of (10-230kDa) wide region; Swimming lane 2 contains the full bacterium lysate of reorganization reorganization pig interferon γ-Fc fusion rotein for ultrasonic degradation; Swimming lane 3 is for cleaning back reorganization pig interferon γ-Fc fusion rotein inclusion body precipitation for the first time with Buffer B; Swimming lane 4 cleans back reorganization pig interferon γ-Fc fusion rotein inclusion body precipitation for the second time for Buffer B, and swimming lane 5 is reorganization pig interferon γ-Fc fusion rotein after the Buffer B renaturation.
Figure 11 is reorganization pig interferon γ-Fc fusion rotein stable western blot figure in porcine blood serum.
Wherein, swimming lane 1 is sample Marker on the albumen that dyes in advance of (10-230kDa) wide region; Swimming lane 2 is not for adding pig interferon γ and reorganization pig interferon γ-Fc fusion rotein pig anteserum sample; Swimming lane 3 is for adding the pig anteserum sample of 1 μ mol/mL pig interferon γ and 1 μ mol/mL reorganization pig interferon γ-Fc fusion rotein 0h; Swimming lane 4 is for adding the pig anteserum sample of 1 μ mol/mL pig interferon γ and 1 μ mol/mL reorganization pig interferon γ-Fc fusion rotein 1h; Swimming lane 5 is for adding the pig anteserum sample of 1 μ mol/mL pig interferon γ and 1 μ mol/mL reorganization pig interferon γ-Fc fusion rotein 8h; Swimming lane 6 is for adding the pig anteserum sample of 1 μ mol/mL pig interferon γ and 1 μ mol/mL reorganization pig interferon γ-Fc fusion rotein 24h; Swimming lane 7 is for adding the pig anteserum sample of 1 μ mol/mL pig interferon γ and 1 μ mol/mL reorganization pig interferon γ-Fc fusion rotein 48h; Swimming lane 8 is for adding the pig anteserum sample of 1 μ mol/mL pig interferon γ and 1 μ mol/mL reorganization pig interferon γ-Fc fusion rotein 72h; Swimming lane 9 is for adding the pig anteserum sample of 1 μ mol/mL pig interferon γ and 1 μ mol/mL reorganization pig interferon γ-Fc fusion rotein 120h.
Embodiment
Below in conjunction with specific embodiment, further set forth the present invention, should be understood that quoting embodiment only is used for explanation the present invention and is not used in and limits the scope of the invention.
Embodiment 1 reorganization pig interferon γ-Fc antigen-4 fusion protein gene optimization design
The contriver is according to the disclosed pig interferon γ of GenBank (Sus scrofa interferon, gamma) cDNA sequence (GenBank accession number: NM_213948.1) and the cDNA sequence of pig IgG Fc fragment (Sus scrofa IgG heavy chain) (GenBank accession number: hinge area, CH2 district and CH3 district NM_213828.1), these 2 genes are directly merged and carry out the codon optimized gene that obtains reorganization pig interferon γ of the present invention-Fc fusion rotein, shown in SEQ ID No:1.
Be reorganization pig interferon γ-Fc fusion rotein to be carried out codon optimized below, each parameter comparison is as follows before and after optimizing:
1. codon adaptation indexI (CAI)
By Fig. 2-a as can be known, before codon is not optimized, reorganization pig interferon γ-Fc antigen-4 fusion protein gene in intestinal bacteria codon adaptation indexI (codon adaptation index is 0.64 CAI).By Fig. 2-b as can be known, after codon optimized, make that γ-Fc antigen-4 fusion protein gene CAI index in intestinal bacteria is 0.84 to the reorganization pig interferon.Usually being considered to this gene during CAI=1 is the optimal state that efficiently expresses in this expression system, therefore the CAI index is more low to show that this gene expression level in this host is more poor, has passed through the gene order that obtains after codon optimized as can be seen and can improve the reorganization pig interferon γ-expression level of Fc antigen-4 fusion protein gene in intestinal bacteria.
2. optimum codon usage frequency (FOP)
By Fig. 3-a as can be known, based on coli expression carrier, before codon was not optimized, it was 8% that per-cent appears in the poor efficiency codon of pig interferon γ-Fc antigen-4 fusion protein gene sequence.The gene that this is not optimized adopts the series connection rare codon, and these codons may reduce translation efficiency, even can dismiss the translation assemblage.By Fig. 3-b as can be known, after codon optimized, the poor efficiency codon appears in reorganization pig interferon γ-Fc antigen-4 fusion protein gene in the intestinal bacteria system frequency is 0.
3.GC base contents (GC curve)
GC content ideal distribution zone is 30%-70%, all can influence to some extent at this any peak of extra-regional appearance and transcribe and translation efficiency.By the GC base average content distributed areas figure contrast of pig interferon γ-Fc antigen-4 fusion protein gene of Fig. 4-a, Fig. 4-b as can be known, by showing among Fig. 4-a in pig interferon γ-Fc antigen-4 fusion protein gene that GC base average content is 52.12% before optimization, eliminated GC content in extra-regional 60 bases of 30%-70% by the sequence that demonstrates among Fig. 4-b after the optimization, the GC base average content of the back reorganization pig interferon γ-Fc fusion rotein that finally is optimized is 50.94%.
3. cis-acting elements
Cis-acting elements Before the optimization After the optimization
E.coli_RBS(AGGAGG) 1 0
PolyT(TTTTTT) 1 0
PolyA(AAAAAAA) 1 0
Ch site (GCTGGTGG) 0 0
T7Cis(ATCTGTT) 0 0
4. removal tumor-necrosis factor glycoproteins
5.mRNA secondary structure prediction figure
After DNA is transcribed into mRNA, because mRNA is the strand linear molecule, make complementary base pair meet by self inflection, the hairpin structure (Hairpin) that forms by hydrogen bonded.5 ' hairpin structure can play regulating and controlling effect in the translation initiation stage.If but hairpin structure is very long, the required energy that unwinds is very high, just might have influence on translation.So the sequence that needs to express should be avoided long and the high hairpin structure of energy as far as possible.After codon optimized, by the secondary structure prediction figure of Fig. 5-a, Fig. 5-b pig interferon γ-codon optimized front and back mRNA of Fc fusion rotein as can be known, 5 ' hairpin structure after the optimization and the required energy that unwinds are more suitable for the expression of target protein.
Embodiment 2: the expression plasmid of reorganization pig interferon γ-Fc antigen-4 fusion protein gene makes up
With the synthetic fragment of reorganization pig interferon γ-full gene of Fc fusion rotein (shown in SEQ ID No:1) after optimizing, be building up in the pUC57 plasmid (being provided by Nanjing Jin Sirui Science and Technology Ltd.), obtain a kind of prolonged preservation plasmid, be designated as pUC57-pIFN γ-Fc plasmid.Be template with pUC57-pIFN γ-Fc plasmid, upstream and downstream are introduced NdeI and XhoI restriction enzyme site respectively, carry out pcr amplification, and the primer sequence is as follows:
Upstream primer:
P1:GGGAATTCCATATGCAGGCCCCGTTCTTCAAGG
Downstream primer:
P2:CCGCTCGAGTCATTTGCCTTGCGTTTTTGAG
Reaction cumulative volume 50 μ L, wherein concentration is that 10 μ mol/L primers respectively add 2.5 μ L, and concentration is that the dNTP of 10mmol/L adds 1 μ L, and used archaeal dna polymerase Phusion High-Fidelity DNA polymerase(is available from Theromo-Fisher scientific), 2U/ μ L adds 0.5 μ L.Reaction conditions is 98 ℃ of 5s, 55 ℃ of 45s, 72 ℃ of 30s, and after 25 circulations, product is through 1.0% agarose gel electrophoresis analysis, and the product size is consistent with expection size (1125bp).(as shown in Figure 7)
The gene product that obtains is reclaimed test kit (available from sky, Beijing root biochemical technology company limited) purifying with dna gel.Behind the purifying, with NdeI and XhoI(available from New England Biolabs company) double digestion, (available from New England Biolabs company) is connected to the product behind the double digestion in the pET21b plasmid (available from Merck company) with the T4 ligase enzyme, be transformed in the DH5 α competent cell (available from sky, Beijing root biochemical technology company limited) 37 ℃ of overnight incubation in the LB flat board of the penbritin that contains 100 μ g/mL (available from Amresco company).Second day screening positive clone bacterium, order-checking, comparison result shows and expected sequence are in full accord, and the expression plasmid of the pig interferon γ-a kind of form of Fc fusion rotein that namely obtains recombinating is designated as pET21b-pIFN γ-Fc.
Embodiment 3 reorganization pig interferon γ-Fc fusion rotein efficiently expressing and identifying in intestinal bacteria
Concrete steps are as follows:
1. the correct pET21b-pIFN γ-Fc plasmid of order-checking comparison among the embodiment 2 is transformed in e. coli bl21 (DE3) the competence bacterial strain (available from sky, Beijing root biochemical technology company limited), in 37 ℃, incubated overnight in containing the penbritin flat board.
2. choose 1-4 reorganization bacterium colony that contains pET21b-pIFN γ-Fc plasmid in second day, insert the LB nutrient solution (available from Amresco company) that contains 100 μ g/mL penbritins, 37 ℃ of overnight incubation.
3. get overnight culture in the 50 μ L steps 2, insert the LB nutrient solution that 5mL contains 100 μ g/mL penbritins, 37 ℃ of shaking culture.
4. bacterium liquid OD is surveyed every 1h in the inoculation back 600Value is treated OD 600=1.0 o'clock, with the IPTG(of 1mmol/L available from Amresco company) carry out abduction delivering.
5. collect bacterium liquid behind the abduction delivering 4h, and high speed centrifugation (rotating speed: 12000rpm) 3min, with the PBS washing and precipitating of precooling, add 5 * sds gel sample loading buffer, 100 ℃ of heating 10min, the room temperature high speed centrifugation (rotating speed: 12000rpm) 1min, get supernatant.Do not add the recombination bacillus coli culture of IPTG by this step process yet.
6. 5 the samples after handling set by step of getting respectively that 10 μ L do not add IPTG and add that IPTG induces, the 10%SDS-PAGE gel electrophoresis analysis.
7.8-15V/cm electrophoresis is moved to separation gel bottom to tetrabromophenol sulfonphthalein.
8. coomassie brilliant blue staining and immunoblotting are observed the expression product band, see Fig. 8-a and Fig. 8-b.
Embodiment 4 reorganization pig interferon γ-Fc fusion roteins efficiently express inductive condition optimization
Many cell growth rates that studies show that have a strong impact on the expression of foreign protein, therefore must be to inoculation amount of bacteria, culture temperature, induce before cell growth time and induce the back cell density to control, overgrowth or overrun and all can influence the expression amount of reorganization pig interferon γ-Fc fusion rotein inclusion body in the intestinal bacteria.Use three factors, four levels, set up IPTG concentration and induction time orthogonal table, induce reorganization pig interferon γ-Fc fusion protein expression by the SDS-PAGE gel electrophoresis analysis.
Concrete steps are as follows:
1. the correct pET21b-pIFN γ-Fc plasmid of order-checking comparison among the embodiment 2 is transformed into BL21(DE3) in the competence bacterial strain (available from sky, Beijing root biochemical technology company limited), incubated overnight in 37 ℃ of penbritin flat boards.
2. next day, picking 1-4 reorganization bacterium colony that contains pET21b-pIFN γ-Fc plasmid inserts the LB nutrient solution that contains 100 μ g/mL penbritins, 37 ℃ of overnight incubation.
3. get overnight culture in the 50 μ l steps 2 and insert the LB inducing culture liquid that 5mL contains 100 μ g/mL penbritins, 37 ℃ of shaking culture.
4. bacterium liquid OD is surveyed in the inoculation back 600Value is treated OD 600=1.0 o'clock, adding concentration according to following table was that 0.5mmol/L, 1.0mmol/L, 1.5mmol/L IPTG carry out abduction delivering.
Table 1 is investigated inductor concentration and the induction time of expression of recombinant proteins
Figure BDA00003196552900101
5.1,2,3, collect reorganization pig interferon γ-Fc fusion rotein bacterium liquid behind the 4h successively, and high speed centrifugation (rotating speed: 12000rpm) 3min, with the PBS washing and precipitating of precooling, add 5 * sds gel sample loading buffer, 100 ℃ of heating 10min, room temperature high speed centrifugation (rotating speed: 12000rpm) 1min.
6. getting 10 μ L does not add IPTG and induces and the reorganization pig interferon γ that adds different concns IPTG, different induction times-Fc fusion rotein culture suspension, 10%SDS-PAGE gel electrophoresis analysis.
7.8-15V/cm electrophoresis is moved to separation gel bottom to tetrabromophenol sulfonphthalein.
8. coomassie brilliant blue staining is observed reorganization pig interferon γ-Fc fusion protein expression products band under each condition.(see figure 9)
9. the gel imaging system thin layer scanning is analyzed express recombinant pig interferon γ-Fc fusion rotein content and is identified pig interferon γ-Fc Expression of Fusion Protein.Final definite inductive condition that is fit to this enforcement is 1mmol/L IPTG, and induction time is 4h.
Embodiment 5 reorganization pig interferon γ-Fc fusion rotein inclusion body purification and renaturation
1. will be among the embodiment 3 collect the intestinal bacteria precipitation of inducing reorganization pig interferon γ-Fc fusion rotein that contains that obtains, resuspended with the PBS of precooling, in 4 ℃ with 12000rpm, centrifugal 15min; Repeat once.
2. inhale and remove supernatant, claim bacterial sediment weight, every gram (weight in wet base) adds lysis buffer Buffer A 5mL, stirs with the slicking glass rod, and thalline is hanged.
3. every gram (weight in wet base) thalline adds 5 μ L 100mmol/L PMSF, and 5 μ L 100mg/mL N,O-Diacetylmuramidases stir 20min on ice.
4. with the broken thalline of sonde-type ultrasonoscope, sample places on ice, and ultrasonic 120 times, each 5s is 5s at interval, circulates three times, is circulated between the cooling sample at every turn and waits for 2min, waits for the sample cooling.4 ℃, 12000rpm, centrifugal 15min.
5. precipitation is washed with lavation buffer solution Buffer B, and 4 ℃, 12000rpm, centrifugal 15min, the precipitation inclusion body repeats once.
6. the inclusion body precipitation stirs 30min with sex change buffer B uffer C dissolving under the room temperature.
7. abundant room temperature 12000rpm behind the mixing, centrifugal 15min abandons precipitation, gets supernatant, the pig interferon γ that namely obtains recombinating-Fc fusion rotein denaturing soln.
8. adopt the dilution refolding method that the reorganization pig interferon γ in the step 7-Fc fusion rotein denaturing soln is carried out renaturation.
Dilution refolding: get an amount of reorganization pig interferon γ-Fc fusion rotein denaturing soln with sex change buffer B uffer C dissolving, with Quick Start Bradford 1x Dye Reagent(U.S. Bio-Rad company) survey its concentration, with renaturation buffer BufferD protein concentration is diluted to 0.2mg/mL then, 4 ℃ of renaturation are during to 24h, recombinant protein solution after the renaturation is filtered with 0.45 μ m filter membrane (Merck Millipore company), namely obtain the reorganization pig interferon γ-Fc fusion rotein solution of lower concentration.With ultrafiltration pipe (the Merck Millipore company) desalination of molecular weight cut-off 10KDa, concentrate, in vacuum freeze drier (Beijing Sihuan Scientific Instrument Factory Co., Ltd) low-temperature vacuum drying, namely obtain reorganization pig interferon γ-Fc fusion rotein powder.
Each damping fluid according to the form below preparation:
Each damping fluid composition of table 2
Figure BDA00003196552900111
9. carry out SDS-PAGE gel electrophoresis (Figure 10) with twice washed product of lavation buffer solution Buffer B in the step 5 respectively, at the visible obviously band of purpose scope.
The preparation of embodiment 6 reorganization pig interferon γ(in detail can referring to the applicant in first to file: 201210593705.X)
Concrete steps are as follows:
1. but make up the recombination bacillus coli of express recombinant pig interferon γ.
According to the disclosed pig interferon γ of GenBank (Sus scrofa interferon, gamma) cDNA sequence (GenBank accession number: NM_213948.1), according to escherichia expression system this gene is carried out obtaining recombinating after codon optimized pig interferon γ gene, shown in SEQ ID No:3.The synthetic fragment of the full gene of reorganization pig interferon γ with after optimizing is building up in the pUC57 plasmid, obtains pUC57-prIFN γ plasmid.
Be template with pUC57-prIFN γ plasmid, the upstream and downstream primer is introduced NdeI and XhoI restriction enzyme site respectively, carries out pcr amplification, and the primer sequence is as follows:
Upstream primer:
P1:GGGAATTCCATATGCAGGCCCCGTTCTTCAAGG
Downstream primer:
P2:CCGCTCGAGTCATTTCGATGCGCGTTGGCC
Reaction cumulative volume 50 μ L, wherein concentration is that 10 μ mol/L primers respectively add 2.5 μ L, concentration is that the dNTP of 10mmol/L adds 1 μ L, used archaeal dna polymerase Phusion High-Fidelity DNA polymerase, 2U/ μ L adds 0.5 μ L.Reaction conditions is 98 ℃ of 5s, 55 ℃ of 20s, 72 ℃ of 30s, 25 circulations.The PCR product with NdeI and XhoI double digestion, is connected in the pET21b plasmid with the T4 ligase enzyme after reclaiming the test kit purifying with dna gel, and plasmid is transformed in the DH5 α competent cell increases.The expression plasmid pET21b-prIFN γ of amplification is transformed in the escherichia coli BL21(DE3) expression bacterial strain.
2. the expression of reorganization pig interferon γ inclusion body
E. coli bl21 (DE3) incubated overnight in 37 ℃ of penbritin flat boards that will contain pET21b-prIFN γ.Choose 1-4 reorganization bacterium colony that contains pET21b-prIFN γ plasmid next day, insert the LB nutrient solution that contains 100 μ g/mL penbritins, 37 ℃ of overnight incubation.Get 50 μ L overnight culture and insert the LB inducing culture liquid that 5mL contains 100 μ g/mL penbritins, 37 ℃ of shaking culture.Treat OD 600=1.0 o'clock, induce with the IPTG of 1mmol/L.Collect bacterium liquid behind the 4h, high speed centrifugation is with the PBS washing and precipitating of precooling.
3. renaturation and the purifying of reorganization pig interferon γ inclusion body
Will be in the step 2 resuspended with the PBS of precooling through the PBS of precooling washing and precipitating, in 4 ℃ with 12000rpm, centrifugal 15min; Repeat once.Abandon supernatant, add lysis buffer Buffer A5mL by every gram (thalline weight in wet base), thalline is hanged.Every gram (thalline weight in wet base) thalline adds 5 μ L 100mmol/L PMSF, and 5 μ L 100mg/mL N,O-Diacetylmuramidases stir 20min on ice.With the broken thalline of sonde-type ultrasonoscope, sample places on ice, and ultrasonic 120 times, each 5s is 5s at interval, circulates three times, is circulated between the cooling sample at every turn and waits for 2min, waits for the sample cooling.4 ℃, 12000rpm, centrifugal 15min.Precipitation is washed with lavation buffer solution Buffer B, and 4 ℃, 12000rpm, centrifugal 15min, the precipitation inclusion body repeats once.The inclusion body precipitation stirs 30min with sex change buffer B uffer C dissolving under the room temperature.Room temperature 12000rpm behind the abundant mixing, centrifugal 15min abandons precipitation, gets supernatant, and pig interferon γ denaturing soln namely obtains recombinating.Adopt dialysis renaturation method renaturation inclusion body: will recombinate pig interferon γ denaturing soln concentration dilution to 0.2mg/mL with sex change buffer B uffer C, inject the dialysis card of molecular weight cut-off 10KDa, 4 ℃ of dialysis renaturation are changed renaturation buffer Buffer D one time every 6h.Renaturation is crossed 0.45 μ m filter membrane with recombinant protein solution after the renaturation during to 24h, namely obtains the reorganization pig interferon γ renaturation solution of lower concentration.With the ultrafiltration pipe desalination of molecular weight cut-off 10KDa, concentrate, in the vacuum freeze drier low-temperature vacuum drying, namely obtain reorganization pig interferon γ powder.Each damping fluid preparation is as shown in table 2.4 ℃ of refrigerators of reorganization pig interferon γ powder are deposited stand-by.
Embodiment 7 reorganization pig interferon γ-Fc fusion rotein Determination of biological activity
(VSV, its TCID50 are 5 * 10 to the pig vesicular stomatitis virus 7/ 100 μ L; academy of agricultural sciences, Guangdong Province veterinary institute provides) but the nephrocyte (PK-15 of infected pigs; academy of agricultural sciences, Guangdong Province veterinary institute provides); the present invention utilizes the antiviral mechanism of pig interferon γ to detect at porcine kidney cell defense reaction to the pig vesicular stomatitis virus under pig interferon γ or reorganization pig interferon γ-Fc fusion rotein existence condition; obtain pig interferon γ or reorganization pig interferon γ-Fc fusion rotein to the protective effect curve of PK-15 cell by the pathology situation that detects the PK-15 cell, thereby measure reorganization pig interferon γ or reorganization pig interferon γ-Fc fusion rotein biologic activity.
1). the positive reference substance formulations prepared from solutions: (pig genetically engineered recombinant cytokine: IFN-LLS-2 is available from the graceful general animal nutrition in Hong Kong company limited to get the pig interferon positive reference substance.), after by specification redissolves, press 10 times of one-level stepwise dilutions with the MEM cell culture fluid (Gibico product) that contains 6% foetal calf serum.
2). reorganization pig interferon γ sample solution preparation: take by weighing the pig interferon γ sample 2.4mg that recombinates after the renaturation among the embodiment 6, after the dissolving of 500 μ L cell culture fluids, do 10 times of one-level stepwise dilutions with cell culture fluid, get 4.8mg/mL, 4.8 * 10 respectively -1Mg/mL, 4.8 * 10 -2Mg/mL, 4.8 * 10 -3Mg/mL, 4.8 * 10 -4Mg/mL, 4.8 * 10 -5Mg/mL recombinant interferon γ solution.
3). reorganization pig interferon γ-Fc fusion protein sample formulations prepared from solutions: take by weighing the pig interferon γ-Fc fusion rotein dry powder sample 350ug that recombinates after the renaturation among the embodiment 5, after the dissolving of 500 μ L cell culture fluids, do 10 times of one-level stepwise dilutions with cell culture fluid, get 35 μ g/mL, 3.5 μ g/mL, 0.35 μ g/mL, 3.5 * 10 respectively -2μ g/mL, 5 * 10 -3μ g/mL, 5 * 10 -4μ g/mL recombinant interferon γ – Fc fusion rotein solution.
4). every hole adds positive controls sample, reorganization pig interferon γ or reorganization pig interferon γ-Fc fusion rotein and the positive control sample solution of different concns on 96 orifice plates, and (cell concn is about 1.8 * 10 to add the fresh PK-15 cell suspension that goes down to posterity of 50 μ L again 6-2.2 * 10 6Individual/mL), total system 100 μ L, 37 ℃, 5%CO 2Hatch about 24h to PK-15 cell attachment under the condition and grow to individual layer.Discard the cell culture fluid supernatant, every hole adds the MEM nutrient solution of 2% foetal calf serum that 100 μ L contain the VSV virus of 100 TCID50.Set up negative control virus group (virus that only adds PK-15 cell and same dose does not add reorganization pig interferon γ) and blank cell control group (only add PK-15 cell and cell culture fluid, do not add reorganization pig interferon γ and virus) simultaneously.37 ℃, 5%CO 2Cultivate 24h under the condition, treat the cytopathy 90%~100% o'clock observations in virus control hole.Amount with the cytopathic Interferon, rabbit that causes the half hole is a unit (being designated as " U ").
Experimental result shows that obvious pathology all takes place the cell in the negative control virus group, and the cell growth is normal in the blank cell control group.Compare with positive control, when the concentration of reorganization pig interferon γ 4.8 * 10 -3Mg/mL~4.8 * 10 -4During mg/mL, the concentration of reorganization pig interferon γ-Fc fusion rotein is in 0.35 μ g/mL~3.5 * 10 -2Begin during μ g/mL to produce and eliminate VSV virus to the phenomenon of the influence of PK-15 cell normal growth.Convert by the result and to determine that tiring of positive control Interferon, rabbit is 3.2 * 10 4U/mL, tiring of reorganization pig interferon γ dilution refolding sample is 2.0 * 10 4U/mL, γ-tire the reorganization pig interferon be 5.8 * 10 by the Fc fusion protein sample 4U/mL.This shows, recombinate pig interferon γ – Fc and positive control and former albumen reorganization pig interferon γ of the present invention compares and has stronger antiviral activity, and preparation technology is simple, show wide application prospect in porkling disease prevention and treatment application reverse side, make may being achieved of suitability for industrialized production genetically engineered reorganization pig interferon γ-Fc.
Embodiment 8 reorganization pig interferon γ-Fc fusion rotein stability tests
In order to detect the reorganization pig interferon γ-stability of Fc fusion rotein in serum, contriver's particular design a kind of in-vitro simulated porcine blood serum environment, reorganization pig interferon γ of the present invention-Fc fusion rotein among the embodiment 5 of preparation reorganization pig interferon γ and 1 μ mol/ml among the embodiment 6 of 1 μ mol/ml is placed fresh porcine blood serum 50 μ L, 37 ℃ jointly, 120rpm, react 0,1,8 respectively, 24, preserve-20 ℃ behind 48,72, the 120h.With mouse-anti pig interferon γ monoclonal antibody (IFN gamma Antibody (P2F6), Catalog Number:MP700, Thermo Pierce) for primary antibodie the pig interferon γ in the porcine blood serum and reorganization pig interferon γ-Fc fusion rotein are carried out the protein immunoblot test, pig interferon γ just can't detect in serum very fast after the reaction as shown in Figure 11, and reorganization pig interferon γ-Fc fusion rotein 120h in serum still keeps stable.This shows that the reorganization pig interferon γ-Fc fusion rotein of the present invention's preparation is compared with pig interferon γ has advantages of higher stability, has prolonged the transformation period in its body, has reached the effect of long-acting administration.
Figure IDA00003196553300011
Figure IDA00003196553300031

Claims (10)

1. reorganization pig interferon γ-Fc fusion rotein, it is characterized in that, described fusion rotein comprises pig interferon gamma portion and Fc fragment part, described pig interferon gamma portion is the full sequence of pig interferon γ extracellular region, described Fc fragment partly comprises hinge area, CH2 district and CH3 district, is directly to merge between pig interferon γ and the Fc fragment part.
2. fusion rotein as claimed in claim 1 is characterized in that, the aminoacid sequence of described fusion rotein is shown in SEQ ID NO:2.
3. gene of the fusion rotein described in the claim 2 of encoding, its base sequence is shown in SEQ ID NO:1.
4. carrier, described carrier contains the gene of claim 3.
5. carrier as claimed in claim 4, described carrier is pET21b.
6. intestinal bacteria, described intestinal bacteria have the carrier of claim 4 or 5.
7. intestinal bacteria as claimed in claim 6, described intestinal bacteria are BL21(DE3) bacterial strain.
8. the procaryotic cell expression method of pig interferon γ-Fc fusion rotein of recombinating comprises the steps:
(1) under appropriate condition, in substratum, cultivates the intestinal bacteria described in the claim 6 or 7;
(2) from intestinal bacteria and/or substratum, separate reorganization pig interferon γ-Fc fusion rotein.
9. expression method as claimed in claim 8 comprises the steps:
(1) picking is one or more contains the intestinal bacteria bacterium colony described in claim 6 or 7, inserts to contain antibiotic LB nutrient solution, overnight incubation;
(2) get overnight culture and transfer in containing antibiotic fresh LB nutrient solution, be cultured to mid-log phase OD in 37 ℃ of concussions 600=1.0;
(3) adding concentration in culture is the IPTG of 1mmol/L, and 37 ℃, behind the abduction delivering 4h, centrifugal treating is collected the coli somatic precipitation that contains reorganization pig interferon γ-Fc fusion rotein.
10. purifying and the refolding method of pig interferon γ-Fc fusion rotein of recombinating is characterized in that, comprises following steps:
(1) as claimed in claim 9 the containing that collection is obtained induced reorganization pig interferon γ-Fc fusion rotein intestinal bacteria precipitation, and PBS is resuspended, and handles in 4 ℃ of high speed centrifugations, repeats once;
(2) supernatant is removed in suction, claims bacterial sediment weight, and every gram (weight in wet base) adds lysis buffer Buffer A3-10mL, stirs damping fluid, and thalline is hanged;
(3) every gram (weight in wet base) thalline adding 3-10 μ L concentration is the PMSF of 100mmol/L, and 3-100 μ L concentration is the N,O-Diacetylmuramidase of 100mg/mL, in stirring on ice;
(4) broken thalline, sample places on ice, and is ultrasonic, and handles in 4 ℃ of high speed centrifugations;
(5) precipitation is washed with lavation buffer solution Buffer B, and handles in 4 ℃ of high speed centrifugations, and the precipitation inclusion body repeats once;
(6) the inclusion body precipitation stirs 30-60min with sex change buffer B uffer C dissolving under the room temperature;
(7) the room temperature high speed centrifugation is handled behind the abundant mixing, abandons precipitation, gets supernatant, the pig interferon γ that namely obtains recombinating-Fc fusion rotein denaturing soln;
(8) get an amount of reorganization pig interferon γ-Fc fusion rotein denaturing soln with sex change buffer B uffer C dissolving, to recombinate the concentration dilution of pig interferon γ-Fc fusion rotein denaturing soln to 0.2mg/mL with renaturation buffer Buffer D, 4 ℃ of dialysis renaturation 24h, with recombinant protein solution after the renaturation with 0.45 μ m membrane filtration, the pig interferon γ that namely obtains recombinating-Fc fusion rotein renaturation solution;
Further ultrafiltration and concentration, desalination are to minimum volume for described reorganization pig interferon γ-Fc fusion rotein renaturation solution, and low-temperature vacuum drying namely obtains reorganization pig interferon γ-Fc powder.
CN201310181765.5A 2013-05-16 2013-05-16 Recombination porcine interferon gamma-Fc fusion protein as well as coding gene and expression method thereof Active CN103232544B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310181765.5A CN103232544B (en) 2013-05-16 2013-05-16 Recombination porcine interferon gamma-Fc fusion protein as well as coding gene and expression method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310181765.5A CN103232544B (en) 2013-05-16 2013-05-16 Recombination porcine interferon gamma-Fc fusion protein as well as coding gene and expression method thereof

Publications (2)

Publication Number Publication Date
CN103232544A true CN103232544A (en) 2013-08-07
CN103232544B CN103232544B (en) 2014-12-10

Family

ID=48880620

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310181765.5A Active CN103232544B (en) 2013-05-16 2013-05-16 Recombination porcine interferon gamma-Fc fusion protein as well as coding gene and expression method thereof

Country Status (1)

Country Link
CN (1) CN103232544B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107177613A (en) * 2017-07-18 2017-09-19 哈尔滨紫霞生物科技有限公司 A kind of method for improving restructuring Porcine interferon-gamma fusion protein antiviral activity
CN107326037A (en) * 2017-07-18 2017-11-07 哈尔滨紫霞生物科技有限公司 A kind of method for improving Recombinant Swine interferon beta fusion protein antiviral activity
CN108840938A (en) * 2017-08-09 2018-11-20 芜湖英特菲尔生物制品产业研究院有限公司 A kind of fusion protein being made of pig albumin and Porcine interferon-gamma and preparation method thereof and a kind of Recombinant Swine long-acting interferon γ

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101967196A (en) * 2010-11-10 2011-02-09 夏志南 Interferon fusion protein, preparation thereof and application thereof
CN103059124A (en) * 2012-12-31 2013-04-24 江苏众红生物工程创药研究院有限公司 Recombined porcine interferon Gamma, coding gene thereof and expressing method
CN103087200A (en) * 2013-01-28 2013-05-08 江苏众红生物工程创药研究院有限公司 Pig IFN (interferon) gamma-Fc fusion protein as well as coding gene and expression method of pig IFN (interferon) gamma-Fc fusion protein

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101967196A (en) * 2010-11-10 2011-02-09 夏志南 Interferon fusion protein, preparation thereof and application thereof
CN103059124A (en) * 2012-12-31 2013-04-24 江苏众红生物工程创药研究院有限公司 Recombined porcine interferon Gamma, coding gene thereof and expressing method
CN103087200A (en) * 2013-01-28 2013-05-08 江苏众红生物工程创药研究院有限公司 Pig IFN (interferon) gamma-Fc fusion protein as well as coding gene and expression method of pig IFN (interferon) gamma-Fc fusion protein

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107177613A (en) * 2017-07-18 2017-09-19 哈尔滨紫霞生物科技有限公司 A kind of method for improving restructuring Porcine interferon-gamma fusion protein antiviral activity
CN107326037A (en) * 2017-07-18 2017-11-07 哈尔滨紫霞生物科技有限公司 A kind of method for improving Recombinant Swine interferon beta fusion protein antiviral activity
CN108840938A (en) * 2017-08-09 2018-11-20 芜湖英特菲尔生物制品产业研究院有限公司 A kind of fusion protein being made of pig albumin and Porcine interferon-gamma and preparation method thereof and a kind of Recombinant Swine long-acting interferon γ

Also Published As

Publication number Publication date
CN103232544B (en) 2014-12-10

Similar Documents

Publication Publication Date Title
CN103570836B (en) A kind of Recombinant Swine interferon beta 1-Fc fusion rotein and encoding gene thereof and expression method
CN103059124B (en) Recombined porcine interferon Gamma, coding gene thereof and expressing method
CN103087200B (en) Pig IFN (interferon) gamma-Fc fusion protein as well as coding gene and expression method of pig IFN (interferon) gamma-Fc fusion protein
CN106282216A (en) A kind of preparation method of recombinant long-acting chicken interferon α
CN103193887B (en) Recombinant porcine IL2-Fc (interteukin-2-Fc) fusion protein as well as encoding gene and expressing method of fusion protein
CN103232545A (en) Recombination porcine interferon alpha1-Fc fusion protein as well as coding gene and expression method thereof
CN103232544B (en) Recombination porcine interferon gamma-Fc fusion protein as well as coding gene and expression method thereof
CN103265637B (en) A kind of Recombinant Swine IL-4-Fc fusion rotein and encoding gene thereof and expression method
CN103319608B (en) Pig IFNalpha1-Fc fusion protein as well as encoding gene and expression method thereof
CN105384826A (en) Cord blood nucleated cell for expressing chimeric antigen receptor and application of cord blood nucleated cell
CN107236039A (en) Recombinate Wzt albumen rabbit anteserum polyclonal antibodies and preparation method thereof
CN103012577B (en) Recombinant porcine interleukin 4, and encoding gene and expression method thereof
CN103059122B (en) Recombined porcine interferon alpha 1, as well as gene encoding gene and expression method thereof
CN106399266A (en) Recombinant baculovirus for expressing dog serum albumin fused interferon gamma and application of recombinant baculovirus
CN103012578B (en) Recombinant porcine interleukin 2, and encoding gene and expression method thereof
CN108558998A (en) Porcine IL-4/6 co-express the preparation and application of recombination yeast bacteria preparation with pig antibacterial peptide is merged
CN103059123B (en) Recombinant porcine interferon beta1, encoding gene and expression method thereof
CN102580074A (en) Riemerella anatipestifer-escherichia coli outer membrane protein bivalent vaccine and preparation method thereof
CN101255189A (en) Animal vaccine immunopotentiator and production method thereof
CN108395480A (en) Chimeric antigen receptor and its gene and recombinant expression carrier, CARHER2-NKT cells and its preparation method and application
CN108948163A (en) Queensland nut plant alexin and its application
CN103509100B (en) A kind of IL-1 R antagonist mutant
CN103497926B (en) The recombinant BCG viable bacteria bacterial strain of expression-secretion mankind p53 albumen, live bacterial vaccines and construction process thereof and application
CN105755008A (en) DNA molecule for coding porcine alpha interferon and expression and purification method of recombinant protein of porcine alpha interferon
CN105085638A (en) KSHV virus vIRF4 DNA binding domain and polyclonal antibody thereof, and preparation method of polyclonal antibody

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee
CP02 Change in the address of a patent holder

Address after: 213125 Jiangsu city of Changzhou Province Cloud River New District No. 518 Changzhou Qianhong biochemical pharmaceutical biological all red

Patentee after: ZonHon Biopharma Institute Inc.

Patentee after: Changzhou Gensun Institute of Biomedicine Co., Ltd.

Address before: 213022 the Yellow River Middle Road, Xinbei District, Jiangsu, China, No. 132, No.

Patentee before: ZonHon Biopharma Institute Inc.

Patentee before: Changzhou Gensun Institute of Biomedicine Co., Ltd.

CP02 Change in the address of a patent holder

Address after: 213125, Yunhe Road, Xinbei District, Jiangsu, Changzhou, 518

Co-patentee after: Changzhou Gensun Institute of Biomedicine Co., Ltd.

Patentee after: ZonHon Biopharma Institute Inc.

Address before: 213125 Jiangsu city of Changzhou Province Cloud River New District No. 518 Changzhou Qianhong biochemical pharmaceutical biological all red

Co-patentee before: Changzhou Gensun Institute of Biomedicine Co., Ltd.

Patentee before: ZonHon Biopharma Institute Inc.

CP02 Change in the address of a patent holder
CP01 Change in the name or title of a patent holder

Address after: 213125 No. 518 Yunhe Road, Xinbei District, Changzhou City, Jiangsu Province

Co-patentee after: Jiangsu Jingsen Biomedical New Materials Technology Co., Ltd.

Patentee after: ZonHon Biopharma Institute Inc.

Address before: 213125 No. 518 Yunhe Road, Xinbei District, Changzhou City, Jiangsu Province

Co-patentee before: Changzhou Gensun Institute of Biomedicine Co., Ltd.

Patentee before: ZonHon Biopharma Institute Inc.

CP01 Change in the name or title of a patent holder
TR01 Transfer of patent right

Effective date of registration: 20190514

Address after: 213125 No. 518 Yunhe Road, Xinbei District, Changzhou City, Jiangsu Province

Patentee after: Jiangsu Jingsen Biomedical New Materials Technology Co., Ltd.

Address before: 213125 No. 518 Yunhe Road, Xinbei District, Changzhou City, Jiangsu Province

Co-patentee before: Jiangsu Jingsen Biomedical New Materials Technology Co., Ltd.

Patentee before: ZonHon Biopharma Institute Inc.

TR01 Transfer of patent right